Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma

Maria Vestergaard, Asger Sverrild, Vibeke Backer, Celeste Porsbjerg
European Respiratory Journal 2014 44: P2046; DOI:
Maria Vestergaard
1Lungemedicinsk Forskningsenhed, Bispebjerg Hospital, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asger Sverrild
1Lungemedicinsk Forskningsenhed, Bispebjerg Hospital, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vibeke Backer
1Lungemedicinsk Forskningsenhed, Bispebjerg Hospital, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Celeste Porsbjerg
1Lungemedicinsk Forskningsenhed, Bispebjerg Hospital, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background and objective:

The American Thoracic society (ATS) suggests fractional exhaled nitric oxide (FeNO) as a marker of eosinophilic airway inflammation. FeNO<25ppb indicates that eosinophilia is unlikely, 25-49ppb indicates possible eosinophilia, and FeNO>50 indicates that eosinophilia is likely. The present study aimed to validate these cut-off values in a non-selected clinical population.

Methods:

All patients referred consecutively over a 12-months period for specialist assessment of asthma at the Respiratory Outpatient Clinic at Bispebjerg Hospital in Copenhagen were examined with FeNO and induced sputum, among others. Eosinophilia was defined as >3% eosinophils in sputum. Sensitivity, specificity and predictive values were assessed for the cut-off values of FeNO. A ROC curve was constructed.

Results:

Of 155 subjects with asthma, 107 were able to produce induced sputum (62% females, mean age 31.7(±14.3). 28 asthmatics had >3% sputum eosinophils. The PPV for FeNO <25ppb, 25-50ppb and >50ppb was 15.6%, 33.3% and 61.5% respectively. The NPV was 84.4%, 66.8% and 28.5% in the corresponding FeNO groups. The sensitivity of the 50 ppb cut-off was 28.6%, increasing to 64.3% at the 25ppb cut-off, whereas the specificity was 93.7% at the 50 ppb cut-off, decreasing to 68.4% at the 25 ppb cut-off. The area under the ROC curve was 0.73.

Conclusion:

Increasing values of PPV was found with increasing cut-off values, indicating the higher FeNO, the greater is the likelihood of eosinophilic inflammation. This supports the proposed cut-points. However, the low sensitivity of the 50ppb cut-off indicates that the 25ppb cut-off should be used when a high sensitivity is required clinically.

  • Asthma - management
  • Nitric oxide
  • Inflammation
  • © 2014 ERS
Previous
Back to top
Vol 44 Issue Suppl 58 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma
Maria Vestergaard, Asger Sverrild, Vibeke Backer, Celeste Porsbjerg
European Respiratory Journal Sep 2014, 44 (Suppl 58) P2046;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma
Maria Vestergaard, Asger Sverrild, Vibeke Backer, Celeste Porsbjerg
European Respiratory Journal Sep 2014, 44 (Suppl 58) P2046;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD
  • Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry
  • Can emphysema predict exacerbations and changes in PFTs in COPD?
Show more 5.2 Monitoring Airway Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society